SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038908
Filing Date
2020-08-10
Accepted
2020-08-10 16:06:13
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20200630.htm   iXBRL 10-Q 2698762
2 EX-31.1 enta-ex311_6.htm EX-31.1 16043
3 EX-31.2 enta-ex312_8.htm EX-31.2 16029
4 EX-32.1 enta-ex321_7.htm EX-32.1 8769
5 GRAPHIC gjq0vhtggk53000001.jpg GRAPHIC 43176
  Complete submission text file 0001564590-20-038908.txt   9155971

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20200630.xsd EX-101.SCH 40277
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20200630_cal.xml EX-101.CAL 60135
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20200630_def.xml EX-101.DEF 115573
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200630_lab.xml EX-101.LAB 358485
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200630_pre.xml EX-101.PRE 285455
11 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20200630_htm.xml XML 1956116
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 201089365
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences